Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

24.38 +0.05 (+0.23%)
Streaming Delayed Price Updated: 11:30 AM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
Healthcare Technology Stocks Q3 Teardown: Hims & Hers Health (NYSE:HIMS) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with Hims... 
Via StockStory
Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
Earnings Scheduled For November 6, 2025
 
Via Benzinga
Earnings Scheduled For August 7, 2025
 
Via Benzinga
PRVA Q3 Deep Dive: Acquisition and Value-Based Care Expansion Shape Outlook
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year... 
Via StockStory
Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q3 2025 Results, Raises Full-Year Guidance
Privia Health's Q3 2025 earnings beat on EPS and raised full-year guidance, driving a positive market reaction despite a revenue miss. 
Via Chartmill
Topics Earnings
Privia Health (NASDAQ:PRVA) Surprises With Strong Q3
Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 32.5% year on year to $580.4 million. The company’s full-year revenue... 
Via StockStory
Privia Health (PRVA) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results this Thursday before market hours. Here’s what investors should know. 
Via StockStory
1 Profitable Stock on Our Buy List and 2 We Question
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Q2 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology for providers stocks fared in Q2,... 
Via StockStory
3 Overrated Stocks That Fall Short
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology industry, including GoodRx (NASDAQ:GDRX) and its peers. 
Via StockStory
3 Cash-Heavy Stocks We Keep Off Our Radar
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care
Privia Health (PRVA) to acquire Evolent Health's (EVH) ACO business for $100M, expanding its value-based care footprint. 
Via Benzinga
What 5 Analyst Ratings Have To Say About Privia Health Gr
 
Via Benzinga
1 Russell 2000 Stock to Consider Right Now and 2 We Brush Off
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
1 Small-Cap Stock with Solid Fundamentals and 2 Facing Headwinds
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Winners And Losers Of Q2: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Healthcare Technology for Providers Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health... 
Via StockStory
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
Breaking Down Privia Health Gr: 4 Analysts Share Their Views
 
Via Benzinga
Why Is Privia Health (PRVA) Stock Soaring Today
Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 6.4% in the morning session after the company announced its Accountable Care Organizations (ACOs) achieved $233.1 million in... 
Via StockStory
Topics Initial Public Offering Lawsuit
Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Omnicell (NASDAQ:OMCL) and its peers. 
Via StockStory
3 Cash-Producing Stocks We Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology stocks, starting... 
Via StockStory
PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects... 
Via StockStory
Beyond The Numbers: 4 Analysts Discuss Privia Health Gr Stock
 
Via Benzinga
Privia Health (NASDAQ:PRVA) Reports Upbeat Q2
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 23.4% year on year to $521.2 million. The company expects... 
Via StockStory
Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q2 2025 Results, Raises Full-Year Guidance Despite Earnings Miss
Privia Health (PRVA) reported mixed Q2 2025 results, missing revenue and EPS estimates but raising full-year guidance, sparking a 6.2% pre-market stock surge. 
Via Chartmill
Privia Health (PRVA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.